Survival and Developmental Milestones Among Pompe Registry Patients with Classic Infantile-Onset Pompe Disease with Different Timing of Initiation of Treatment with Enzyme Replacement Therapy
J Neuromuscul Dis
.
2015;2(s1):S61-S62.
Authors
Yin-Hsiu Chien
1
,
Ans van der Ploeg
2
,
Simon Jones
3
,
Barry Byrne
4
,
Ashok Vellodi
5
,
Nancy Leslie
6
,
Eugen Mengel
7
,
Suma P Shankar
8
,
Pranoot Tanpaiboon
9
,
David W Stockton
10
,
Julia B Hennermann
11
,
Zsuzsanna Devecseri
12
,
Judy Kempf
12
,
Joan Keutzer
12
,
Priya Kishnani
13
Affiliations
1
National Taiwan University Hospital, Taipei, Taiwan.
2
Department of Pediatrics & Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Rotterdam, Netherlands.
3
Manchester Center for Genomic Medicine, CMFT, University of Manchester, UK.
4
Department of Pediatrics, University of Florida, Gainesville, FL, USA.
5
Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
6
Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
7
University of Mainz, Mainz, Germany.
8
Emory University School of Medicine, Atlanta, GA, USA.
9
Children's National Medical Center, Washington, DC, USA.
10
Wayne State University School of Medicine, Detroit, MI, USA.
11
Charite Universitaetsmedizin Berlin, Berlin, Germany.
12
Genzyme, a Sanofi company, Cambridge, MA, USA.
13
Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.
PMID:
27858651
No abstract available